The article challenges the concept of “corporate memory” within large CROs, arguing that while it seems appealing, it often fails in the context of complex, evolving clinical trials. It highlights that despite a CRO’s claimed experience and success, the ability to replicate past successes is hindered by the dynamic nature of clinical research. The article emphasizes the need for a more tailored approach to clinical trial management rather than relying on an illusory corporate memory.
